Page last updated: 2024-08-16

timolol and sdz glc 756

timolol has been researched along with sdz glc 756 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Greiner, B; Laengle, UW; Markstein, R; Roman, D; Schneider, V1
Court, M; Germann, PG; Laengle, UW; Markstein, R; Nogues, V; Roman, D1
Laengle, UW; Markstein, R; Pralet, D; Roman, D; Seewald, W1

Other Studies

3 other study(ies) available for timolol and sdz glc 756

ArticleYear
Effects of antiglaucoma drugs timolol and GLC756, a novel dopamine D2 agonist and D1 antagonist, on endotoxin-induced-uveitis in rats.
    Experimental eye research, 2005, Volume: 80, Issue:6

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Aqueous Humor; Betamethasone; Dopamine Agents; Eye Proteins; Glaucoma; Injections, Subcutaneous; Lipopolysaccharides; Quinolines; Rats; Rats, Inbred Lew; Timolol; Tumor Necrosis Factor-alpha; Uveitis

2005
Effects of anti-glaucoma drugs timolol and GLC756, a novel mixed dopamine D2 receptor agonist and D1 receptor antagonist, on endotoxin-induced-uveitis and -arthritis in rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2005, Volume: 57, Issue:2

    Topics: Animals; Arthritis; Glaucoma; Lipopolysaccharides; Quinolines; Rats; Rats, Inbred Lew; Receptors, Dopamine D1; Receptors, Dopamine D2; Timolol; Uveitis

2005
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells.
    Experimental eye research, 2006, Volume: 83, Issue:6

    Topics: Animals; Antihypertensive Agents; Cell Death; Dose-Response Relationship, Drug; Latanoprost; Mast Cells; Prostaglandins F, Synthetic; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Timolol; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2006